APA (7th ed.) Citation

Ferreira-da-silva, R., Silva, L., Costa-Santos, C., Morato, M., Polónia, J. J., Ribeiro-Vaz, I., . . . Melo, M. (2025). Post-marketing surveillance study on the effectiveness and safety of molnupiravir in high-risk COVID-19 outpatients. Pharmacological Reports, 1-12. https://doi.org/10.1007/s43440-025-00729-2

Chicago Style (17th ed.) Citation

Ferreira-da-silva, Renato, et al. "Post-marketing Surveillance Study on the Effectiveness and Safety of Molnupiravir in High-risk COVID-19 Outpatients." Pharmacological Reports 2025: 1-12. https://doi.org/10.1007/s43440-025-00729-2.

MLA (9th ed.) Citation

Ferreira-da-silva, Renato, et al. "Post-marketing Surveillance Study on the Effectiveness and Safety of Molnupiravir in High-risk COVID-19 Outpatients." Pharmacological Reports, 2025, pp. 1-12, https://doi.org/10.1007/s43440-025-00729-2.